http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2560691-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1be568453ffebd8d1db582e0a147161
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16515ac4fc328f1206048b8b2d416b3b
publicationDate 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2560691-C2
titleOfInvention Pharmaceutical compositions based on n-carbamoyl-methyl-4-phenyl-2-pyrrolidone
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to field of medicine, pharmacology and chemical-pharmaceutical industry and deals with medications which influence neurological and mnestic functions in people. Target of claimed invention consists in development of stable, economically expedient, industrially realisable, preparative form of N-carbamoyl-methyl-4-phenyl-2-pyrrolidone. Set task is solved by mixing N-carbamoyl-methyl-4-phenyl-2-pyrrolidone and selected pharmaceutically acceptable additional substances with water. n EFFECT: creation of drug form in such form makes it possible to extend technological possibilities and economical expediency of finished medication production. n 9 cl, 4 ex
priorityDate 2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2240783-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23109652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423086287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448178750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154

Total number of triples: 40.